David J Mazzo has an estimated net worth of $4.77 Million. This is based on reported shares across multiple companies, which include EyePoint Pharmaceuticals, Inc., Seneca Biopharma, Inc., LISATA THERAPEUTICS, INC., AVANIR PHARMACEUTICALS, INC., and Regado Biosciences Inc.
2018 was David J Mazzo's most active year for acquiring shares with 10 total transactions. David J Mazzo's most active month to acquire stocks was the month of December. 2019 was David J Mazzo's most active year for disposing of shares, totalling 6 transactions. David J Mazzo's most active month to dispose stocks was the month of December. 2018 saw David J Mazzo paying a total of $423,312.00 for 331,150 shares, this is the most they've acquired in one year. In 2015 David J Mazzo cashed out on 550,535 shares for a total of $454,261.80, their largest year based on trade value.